CC Bio.

CC Bio. has developed a proprietary drug discovery platform, Zeus, for therapeutic discovery methods to diagnose and treat microbiome-based diseases. The company uses customized and precise synthetic biology to design and edit the microbiome with surgical precision to eliminate microbiome-based diseases in an effective, specific, and preventive manner, enabling healthcare professionals to prevent misdiagnosis and over-prescription of medications for patients.